Correlation Between Ocuphire Pharma and Nabriva Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ocuphire Pharma and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocuphire Pharma and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocuphire Pharma and Nabriva Therapeutics AG, you can compare the effects of market volatilities on Ocuphire Pharma and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocuphire Pharma with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocuphire Pharma and Nabriva Therapeutics.
Diversification Opportunities for Ocuphire Pharma and Nabriva Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ocuphire and Nabriva is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Ocuphire Pharma and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and Ocuphire Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocuphire Pharma are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of Ocuphire Pharma i.e., Ocuphire Pharma and Nabriva Therapeutics go up and down completely randomly.
Pair Corralation between Ocuphire Pharma and Nabriva Therapeutics
If you would invest 162.00 in Nabriva Therapeutics AG on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Nabriva Therapeutics AG or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.94% |
| Values | Daily Returns |
Ocuphire Pharma vs. Nabriva Therapeutics AG
Performance |
| Timeline |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nabriva Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Ocuphire Pharma and Nabriva Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ocuphire Pharma and Nabriva Therapeutics
The main advantage of trading using opposite Ocuphire Pharma and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocuphire Pharma position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |